October 31, 2014 9:08 PM ET


Company Overview of Transplant Genomics, Inc.

Company Overview

Transplant Genomics, Inc., a molecular diagnostic company, develops molecular diagnostic tests that detect early signs of graft injury, differentiate among actionable causes, and enable optimization of therapy. It focuses on improving organ transplant outcomes. The company was founded in 2013 and is based in Brookline, Massachusetts.

1501 Beacon Street

Suite 1903

Brookline, MA 02446

United States

Founded in 2013



Key Executives for Transplant Genomics, Inc.

Chief Executive Officer and President
Age: 58
Chief Clinical Advisor
Chief Scientific Advisor
Compensation as of Fiscal Year 2014.

Transplant Genomics, Inc. Key Developments

Transplant Genomics Announces an Exclusive License to Patent Rights Co-Owned by The Scripps Research Institute and Northwestern University

Transplant Genomics announced it has an exclusive license to patent rights co-owned by The Scripps Research Institute and Northwestern University. According to announcement, the company intends to develop and commercialize tests to monitor how well transplants are faring, and to detect and respond to early signs of problems with the graft. It first plans to focus on a test for kidney transplant recipients that can show when treatment or biopsy is required based on analysis of a patient's blood.

Similar Private Companies By Industry

Company Name Region
King Pharmaceuticals Research & Development Inc. United States
Muskogee Clinical Laboratory, Inc. United States
Nano Precision Medical, Inc. United States
LayerBio, Inc. United States
XL Techgroup, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Transplant Genomics, Inc., please visit www.transplantgenomics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.